Skip to main content

Scales for Adverse Effects

By

Adverse Effects

This domain mainly consists of two parts—EPS and non-EPS adverse effects. As for the former, the combination of the AIMS (tardive involuntary movement), BARS (akathisia) and SAS (parkinsonism) appear to have been ‘a standard’. The ESRS has been much less commonly used although comprehensive, well presumably due to a lengthy process to complete. This topic has recently been reviewed in detail elsewhere.24 A major challenge here is how to interpret different scales with different item numbers as ‘an overall EPS burden’ within the subject in question. The drug-induced extrapyramidal symptoms scale: DIEPSS25 (nine items) might represent a useful alternative.

 

Non-motor adverse effects, including anticholinergic, metabolic, autonomic and sexual problems, have been usually described without the usage of the scales and sometimes reported in the table, for which standardization is warranted.26 Evaluations that depend on the spontaneous reports may result in underestimation. Although the UKU side effect rating scale has been occasionally used, it still lacks some crucial elements such as metabolic parameters, for which a significant impact in this population is noted27 and regular monitoring is recommended.28 This may be due to the fact that it was published before newer antipsychotic medications, which are relatively more problematic in terms of metabolic disturbances in general, have become widely available in the market.

 

An obvious difficulty for the scales with multiple items is an inherent non-comparability of the same total score for differently endorsed problems (e.g., the possibly non-uniform implication of moderate severity in metabolic versus sexual adverse effects) as well as validity and pragmatic usefulness in severity differentials (e.g., 0–3 (none, mild, moderate, and severe) versus more detailed 0–5 (none, equivocal, mild, moderate, marked and severe)).


Copyright Notice

Adapted from Wikipedia. Text is available under the Creative Commons Attribution-ShareAlike License 3.0; additional terms may apply.

Labels:

Comments

Post a Comment

Your Thoughts?

Popular posts from this blog

ADVOKATE: A Mnemonic Tool for the Assessment of Eyewitness Evidence

By
ADVOKATE: A Mnemonic Tool for Assessment of Eyewitness Evidence A tool for assessing eyewitness  ADVOKATE is a tool designed to assess eyewitness evidence and how much it is reliable. It requires the user to respond to several statements/questions. Forensic psychologists, police or investigative officer can do it. The mnemonic ADVOKATE stands for: A = amount of time under observation (event and act) D = distance from suspect V = visibility (night-day, lighting) O = obstruction to the view of the witness K = known or seen before when and where (suspect) A = any special reason for remembering the subject T = time-lapse (how long has it been since witness saw suspect) E = error or material discrepancy between the description given first or any subsequent accounts by a witness.  Working with suspects (college.police.uk)
Post a Comment
Read more

ICD-11 Criteria for Attention Deficit Hyperactivity Disorder (ADHD) 6A05

By
ICD-11 Criteria for Attention Deficit Hyperactivity Disorder (ADHD) 6A05 Attention deficit hyperactivity disorder is characterised by a persistent pattern (at least 6 months) of inattention and/or hyperactivity-impulsivity that has a direct negative impact on academic, occupational, or social functioning. There is evidence of significant inattention and/or hyperactivity-impulsivity symptoms prior to age 12, typically by early to mid-childhood, though some individuals may first come to clinical attention later. The degree of inattention and hyperactivity-impulsivity is outside the limits of normal variation expected for age and level of intellectual functioning. Inattention refers to significant difficulty in sustaining attention to tasks that do not provide a high level of stimulation or frequent rewards, distractibility and problems with organisation. Hyperactivity refers to excessive motor activity and difficulties with remaining still, most evident in structured situations that re...
Post a Comment
Read more

ICD-11 Criteria for Depression (Recurrent Depressive Disorder) 6A71

By
ICD-11 Criteria for Depression (Recurrent Depressive Disorder) 6A71 Recurrent depressive disorder is characterised by a history or at least two depressive episodes separated by at least several months without significant mood disturbance. A depressive episode is characterised by a period of depressed mood or diminished interest in activities occurring most of the day, nearly every day during a period lasting at least two weeks accompanied by other symptoms such as difficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor agitation or retardation, and reduced energy or fatigue. There have never been any prior manic, hypomanic, or mixed episodes, which would indicate the presence of a Bipolar disorder. Inclusions:                Seasonal depressive disorder Exclusions:    ...
Post a Comment
Read more